These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33312717)

  • 1. Plasma cholesterol in Alzheimer's disease and frontotemporal dementia.
    Wang P; Zhang H; Wang Y; Zhang M; Zhou Y
    Transl Neurosci; 2020; 11(1):116-123. PubMed ID: 33312717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered High Density Lipoprotein Composition in Behavioral Variant Frontotemporal Dementia.
    Kim WS; He Y; Phan K; Ahmed RM; Rye KA; Piguet O; Hodges JR; Halliday GM
    Front Neurosci; 2018; 12():847. PubMed ID: 30487733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Apolipoprotein E ε4 Allele-Dependent Relationship Between Serum Lipid Levels and Cognitive Function: A Population-Based Cross-sectional Study.
    Wei S; Gao L; Jiang Y; Shang S; Chen C; Dang L; Wang J; Huo K; Wang J; Qu Q
    Front Aging Neurosci; 2020; 12():44. PubMed ID: 32231559
    [No Abstract]   [Full Text] [Related]  

  • 4. Associations between APOE polymorphisms and seven diseases with cognitive impairment including Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies in southeast China.
    Chen KL; Sun YM; Zhou Y; Zhao QH; Ding D; Guo QH
    Psychiatr Genet; 2016 Jun; 26(3):124-31. PubMed ID: 26981880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia.
    Agosta F; Vossel KA; Miller BL; Migliaccio R; Bonasera SJ; Filippi M; Boxer AL; Karydas A; Possin KL; Gorno-Tempini ML
    Proc Natl Acad Sci U S A; 2009 Feb; 106(6):2018-22. PubMed ID: 19164761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ε3/4 genotype of the apolipoprotein E is associated with higher risk of Alzheimer's disease in patients with type 2 diabetes mellitus.
    Tang Y; Li YM; Zhang M; Chen YQ; Sun Q
    Gene; 2019 Jun; 703():65-70. PubMed ID: 30890475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene dose effect of the APOE-epsilon4 allele on plasma HDL cholesterol level in patients with Alzheimer's disease.
    Hoshino T; Kamino K; Matsumoto M
    Neurobiol Aging; 2002; 23(1):41-5. PubMed ID: 11755017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOE ε2 and ε4 influence the susceptibility for Alzheimer's disease but not other dementias.
    Lovati C; Galimberti D; Albani D; Bertora P; Venturelli E; Cislaghi G; Guidi I; Fenoglio C; Cortini F; Clerici F; Finazzi D; Forloni G; Scarpini E; Mariani C
    Int J Mol Epidemiol Genet; 2010 Apr; 1(3):193-200. PubMed ID: 21537391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring quantitative group-wise differentiation of Alzheimer's disease and behavioural variant frontotemporal dementia using tract-specific microstructural white matter and functional connectivity measures at multiple time points.
    Meijboom R; Steketee RME; Ham LS; Mantini D; Bron EE; van der Lugt A; van Swieten JC; Smits M
    Eur Radiol; 2019 Oct; 29(10):5148-5159. PubMed ID: 30859283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and Cognitive Decline of Alzheimer's Disease and Other Dementia by Apolipoprotein ε4 Allele Presence: A Community-Based Cohort Study in Korean Elderly.
    Yoo SY; Han A; Park S; Lee JY
    Psychiatry Investig; 2022 Mar; 19(3):190-196. PubMed ID: 35232006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia.
    Geschwind D; Karrim J; Nelson SF; Miller B
    Ann Neurol; 1998 Jul; 44(1):134-8. PubMed ID: 9667603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.
    Sando SB; Melquist S; Cannon A; Hutton ML; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly JO
    BMC Neurol; 2008 Apr; 8():9. PubMed ID: 18416843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the Relationship between Apolipoprotein E Alleles and Serum Lipids in Alzheimer's Disease: A Meta-Analysis.
    Xu H; Fu J; Mohammed Nazar RB; Yang J; Chen S; Huang Y; Bao T; Chen X
    Brain Sci; 2023 Nov; 13(11):. PubMed ID: 38002514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid metabolism in cognitive decline and dementia.
    Panza F; D'Introno A; Colacicco AM; Capurso C; Pichichero G; Capurso SA; Capurso A; Solfrizzi V
    Brain Res Rev; 2006 Aug; 51(2):275-92. PubMed ID: 16410024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of cognitive function, behavioral and psychological symptoms in patients with Alzheimer's disease versus behavioral variant frontotemporal dementia].
    Zhang LL; Wang Y; Cheng Y; Zhang N
    Zhonghua Nei Ke Za Zhi; 2017 Dec; 56(12):903-908. PubMed ID: 29202529
    [No Abstract]   [Full Text] [Related]  

  • 16. Regional differences in white matter breakdown between frontotemporal dementia and early-onset Alzheimer's disease.
    Lu PH; Lee GJ; Shapira J; Jimenez E; Mather MJ; Thompson PM; Bartzokis G; Mendez MF
    J Alzheimers Dis; 2014; 39(2):261-9. PubMed ID: 24150110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of apolipoprotein E (APO E) polymorphism on leptin in Alzheimer's disease.
    Agarwal R; Talwar P; Kushwaha SS; Tripathi CB; Kukreti R
    Ann Indian Acad Neurol; 2015; 18(3):320-6. PubMed ID: 26425011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cross-sectional study of inpatients with late stage of dementia in Southeast China and the associations between biochemical parameters and apolipoprotein E genotypes.
    Jiang B; Zhang XP; Chen MF; Wang Z; Zhao MX; Chen BH; Li HL
    Clin Interv Aging; 2018; 13():159-163. PubMed ID: 29416324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Alzheimer's Disease and Apolipoprotein E Polymorphisms.
    Gozalpour E; Kamali K; Mohammd K; Khorshid HK; Ohadi M; Karimloo M; Mirabzadeh A; Fotouhi A
    Iran J Public Health; 2010; 39(2):1-6. PubMed ID: 23112999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipidomics Analysis of Behavioral Variant Frontotemporal Dementia: A Scope for Biomarker Development.
    Kim WS; Jary E; Pickford R; He Y; Ahmed RM; Piguet O; Hodges JR; Halliday GM
    Front Neurol; 2018; 9():104. PubMed ID: 29541056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.